|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.25 SEK | -0.21% |
|
-1.02% | -19.44% |
| 06-09 | Orexo AB Announces Appointment of Raheleh Nassaji as Senior Vice President Business Development | CI |
| 06-09 | Orexo appoints new Head of Business Development | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OREXO AB | Specialty & Advanced Pharmaceuticals | -0.21% | -1.02% | -19.44% | +20.65% | -38.23% | 87.8M |  |  | |
- Stock Market
- Stocks
- ORX Stock
- Charts Orexo AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
